Close

Tag: Coronavirus information (COVID-19)

Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen’s COVID-19 Vaccine Candidate

Johnson & Johnson announced the launch of its large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) for its COVID-19 vaccine candidate, JNJ-78436735, being developed by...

Sanofi and GSK sign agreements with the Government of Canada to supply up to 72 million doses of adjuvanted COVID-19 vaccine

Sanofi and GSK have signed agreements with the Government of Canada for the supply of up to 72 million doses of an adjuvanted COVID-19...

Russia Expects To Register Second COVID-19 Vaccine EpiVacCorona By Oct 15

Russia expects to register another COVID-19 vaccine candidate by mid-October, according to Russian consumer safety watchdog Rospotrebnadzor. Russia expects to register another COVID-19 vaccine candidate...

Biocair: Transporting Temperature-Sensitive COVID-19 Vaccines

We all hope that a COVID-19 vaccine is on the horizon - but the global cold chain must be prepared to distribute these vaccines...

BioNTech to Acquire GMP Manufacturing Site to Expand COVID-19 Vaccine Production Capacity in First Half 2021

BioNTech SE announced the signing of a share purchase agreement with Novartis AG, Basel / Switzerland to acquire their GMP certified manufacturing facility in...

RECOVERY COVID-19 Phase 3 Trial to Evaluate Regeneron’s REGN-COV2 Investigational Antibody Cocktail in the UK

Regeneron Pharmaceuticals, Inc. and the University of Oxford today announced that RECOVERY (Randomised Evaluation of COVid-19 thERapY), one of the world's largest randomized clinical...

Lilly announces proof of concept data for neutralizing antibody LY-CoV555 in the COVID-19 outpatient setting

Eli Lilly and Company announced proof of concept data from an interim analysis of the BLAZE-1 clinical trial, showing a reduced rate of hospitalization...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read